118 related articles for article (PubMed ID: 1659612)
21. Reversible inhibitors of the gastric (H+/K+)-ATPase. 3. 3-substituted-4-(phenylamino)quinolines.
Ife RJ; Brown TH; Keeling DJ; Leach CA; Meeson ML; Parsons ME; Reavill DR; Theobald CJ; Wiggall KJ
J Med Chem; 1992 Sep; 35(18):3413-22. PubMed ID: 1326634
[TBL] [Abstract][Full Text] [Related]
22. Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase.
Fellenius E; Berglindh T; Sachs G; Olbe L; Elander B; Sjöstrand SE; Wallmark B
Nature; 1981 Mar; 290(5802):159-61. PubMed ID: 6259537
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of the gastric H+,K+ -ATPase by plectrinone A, a diterpenoid isolated from Plectranthus barbatus Andrews.
Schultz C; Bossolani MP; Torres LM; Lima-Landman MT; Lapa AJ; Souccar C
J Ethnopharmacol; 2007 Apr; 111(1):1-7. PubMed ID: 17166678
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of (H+ + K+)-ATPase and H+ accumulation in hog gastric membranes by trifluoperazine, verapamil and 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate.
Im WB; Blakeman DP; Mendlein J; Sachs G
Biochim Biophys Acta; 1984 Feb; 770(1):65-72. PubMed ID: 6320882
[TBL] [Abstract][Full Text] [Related]
25. (+)-Curcuphenol and dehydrocurcuphenol, novel sesquiterpenes which inhibit H,K-ATPase, from a marine sponge Epipolasis sp.
Fusetani N; Sugano M; Matsunaga S; Hashimoto K
Experientia; 1987 Dec; 43(11-12):1234-5. PubMed ID: 2826218
[TBL] [Abstract][Full Text] [Related]
26. Effects of the enantiomers of lansoprazole (AG-1749) on (H+ + K+)-ATPase activity in canine gastric microsomes and acid formation in isolated canine parietal cells.
Nagaya H; Inatomi N; Nohara A; Satoh H
Biochem Pharmacol; 1991 Oct; 42(10):1875-8. PubMed ID: 1660270
[TBL] [Abstract][Full Text] [Related]
27. Bioactive diterpenoids and flavonoids from the aerial parts of Scoparia dulcis.
Liu Q; Yang QM; Hu HJ; Yang L; Yang YB; Chou GX; Wang ZT
J Nat Prod; 2014 Jul; 77(7):1594-600. PubMed ID: 24955889
[TBL] [Abstract][Full Text] [Related]
28. Novel indanyl-substituted imidazo[1,2-a]pyridines as potent reversible inhibitors of the gastric H+/K+-ATPase.
Zimmermann PJ; Buhr W; Brehm C; Palmer AM; Feth MP; Senn-Bilfinger J; Simon WA
Bioorg Med Chem Lett; 2007 Oct; 17(19):5374-8. PubMed ID: 17723299
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of gastric H+,K(+)-ATPase by the anti-ulcer agent, sofalcone.
Murakami S; Muramatsu M; Aihara H; Otomo S
Biochem Pharmacol; 1991 Sep; 42(7):1447-51. PubMed ID: 1656986
[TBL] [Abstract][Full Text] [Related]
30. Sulfide and sulfoxide derivatives of substituted benzimidazoles inhibit acid formation in isolated gastric glands by different mechanisms.
Fryklund J; Wallmark B
J Pharmacol Exp Ther; 1986 Jan; 236(1):248-53. PubMed ID: 3001289
[TBL] [Abstract][Full Text] [Related]
31. Ro 18-5364, a potent new inhibitor of the gastric (H+ + K+)-ATPase.
Sigrist-Nelson K; Krasso A; Müller RK; Fischli AE
Eur J Biochem; 1987 Jul; 166(2):453-9. PubMed ID: 3038541
[TBL] [Abstract][Full Text] [Related]
32. AHR-9294: a novel inhibitor of H,K-ATPase antagonizes gastric HCl secretion in vivo.
Reenstra WW; Pinkus LM; Bailey J; Smith WL; Droppleman D; Sancilio LF; Forte JG
J Pharmacol Exp Ther; 1992 May; 261(2):737-45. PubMed ID: 1315865
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of (aryloxy)alkylamines. 1. Novel antisecretory agents with H+K+-ATPase inhibitory activity.
Sanfilippo PJ; Urbanski M; Press JB; Hajos ZG; Shriver DA; Scott CK
J Med Chem; 1988 Sep; 31(9):1778-85. PubMed ID: 2842503
[TBL] [Abstract][Full Text] [Related]
34. Studies on (H(+)-K+)-ATPase inhibitors of gastric acid secretion. Prodrugs of 2-[(2-pyridinylmethyl)sulfinyl]benzimidazole proton-pump inhibitors.
Sih JC; Im WB; Robert A; Graber DR; Blakeman DP
J Med Chem; 1991 Mar; 34(3):1049-62. PubMed ID: 1848293
[TBL] [Abstract][Full Text] [Related]
35. Effect of stilbene derivatives on gastric H+, K(+)-ATPase.
Murakami S; Arai I; Muramatsu M; Otomo S; Baba K; Kido T; Kozawa M
Biochem Pharmacol; 1992 Nov; 44(10):1947-51. PubMed ID: 1333200
[TBL] [Abstract][Full Text] [Related]
36. SK&F 96067 is a reversible, lumenally acting inhibitor of the gastric (H+ + K+)-ATPase.
Keeling DJ; Malcolm RC; Laing SM; Ife RJ; Leach CA
Biochem Pharmacol; 1991 Jun; 42(1):123-30. PubMed ID: 1648919
[TBL] [Abstract][Full Text] [Related]
37. Indomethacin inhibition of hog gastric H+/K(+)-ATPase arises from its effect on both the enzyme protein and the lipid bilayer.
Du J; Li SG; Lin ZH
J Biochem; 1994 Aug; 116(2):250-6. PubMed ID: 7822239
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological profile of novel acid pump antagonist 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methyl cyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526).
Ito K; Kinoshita K; Tomizawa A; Inaba F; Morikawa-Inomata Y; Makino M; Tabata K; Shibakawa N
J Pharmacol Exp Ther; 2007 Oct; 323(1):308-17. PubMed ID: 17630360
[TBL] [Abstract][Full Text] [Related]
39. Soraprazan: setting new standards in inhibition of gastric acid secretion.
Simon WA; Herrmann M; Klein T; Shin JM; Huber R; Senn-Bilfinger J; Postius S
J Pharmacol Exp Ther; 2007 Jun; 321(3):866-74. PubMed ID: 17369284
[TBL] [Abstract][Full Text] [Related]
40. Reversible inhibitors of the gastric (H+/K+)-ATPase. 1. 1-Aryl-4-methylpyrrolo[3,2-c]quinolines as conformationally restrained analogues of 4-(arylamino)quinolines.
Brown TH; Ife RJ; Keeling DJ; Laing SM; Leach CA; Parsons ME; Price CA; Reavill DR; Wiggall KJ
J Med Chem; 1990 Feb; 33(2):527-33. PubMed ID: 2153816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
